Cremasco Medicina Diagnóstica

What Cremasco Medicina Diagnóstica does

Cremasco Medicina Diagnóstica is a Brazilian diagnostic medicine provider operating 12 physical units across Greater Vitória in Espírito Santo state (Cariacica, Vila Velha, Vitória, and Serra), serving individual patients primarily through private health insurance coverage. Founded in 1978 as Laboratório Barnard and renamed in 1989, the company has built a 48-year operational track record in the regional market, processing more than 50,000 diagnostic examinations monthly with a workforce of 100+ medical specialists. Services are billed through 28+ health insurance provider networks (convênios) including Amil, Bradesco Saúde, Unimed, SulAmérica, Cassi, Petrobras, Vale, and MedSenior, with direct out-of-pocket payment available for uninsured or non-covered services.

The company offers an integrated diagnostic platform spanning five service lines: clinical analysis (3,000+ test types with 24-hour digital results and double validation), diagnostic imaging (multislice CT, 1.5T MRI, color Doppler ultrasound, digital radiology with dual specialist reading), specialized consultations (cardiology, endocrinology, gynecology, urology, internal medicine with telemedicine), pathological anatomy (digital microscopy with whole-slide imaging and permanent slide printing), and molecular biology (PCR panels, genetic panels, NGS sequencing, pharmacogenomics). Supporting technology infrastructure includes home collection service with biosafety protocols, an online patient results portal with longitudinal comparison and 24/7 support, EMR integration, LGPD-compliant data handling, and a planned 2026 platform fusion of Clinux and Matrix Diagnosis systems.

Cremasco operates as part of MDG Group, a diversified healthcare conglomerate whose subsidiaries (Unirad, Climp, Imagem Diagnóstico, Deomar, DES, CMC, MedConsulta) provide complementary diagnostic and consultation services that enable cross-referrals and integrated patient pathways within the network. Go-to-market is direct-to-consumer through owned physical units, supplemented by home collection and WhatsApp-based appointment booking, with patient acquisition driven primarily by inclusion in health insurance networks. The company is a private limitada (LLC) legally registered in Cariacica, Espírito Santo (CNPJ 31.815.525/0001-09), and remains under family clinical leadership.

Name

Cremasco Medicina Diagnóstica

Legal name

Cremasco Medicina Diagnóstica Ltda

Website

https://cremascomedicina.com.br

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Cremasco Medicina Diagnóstica is a Brazilian diagnostic medicine provider operating 12 units across Greater Vitória, Espírito Santo, processing 50,000+ exams monthly. It delivers integrated clinical, imaging, pathology, and molecular biology services through 28+ health insurance networks, as part of MDG Group.

Ownership category

akta.pro rank

Product category

Diagnostic Medicine Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAGAAAE

Central Laboratory & Clinical Trial Testing CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHSABACAN

Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home)

Home & Personal Services/Elder Care & In-Home Care Services/Skilled Nursing & Clinical Home Health

SECONDARYHLAGACAJ

Clinical Trial Sample Collection & Site Phlebotomy Services

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

Keywords

• Diagnostic medicine services
• Clinical laboratory testing
• Medical imaging diagnostics
• Molecular biology diagnostics
• Anatomical pathology services

Headquarters

HQ city

Cariacica

HQ country

Brazil

HQ region

Latin America

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Health Insurance (Convênio) Services: Diagnostic services billed through health insurance providers. The company accepts 28+ insurance plans including Amil, Bradesco Saúde, Unimed, SulAmérica, Cassi, Petrobras, Vale, and others, covering laboratory tests, diagnostic imaging, and anatomical pathology.
2. Direct Patient Payment: Out-of-pocket payments for services not covered by insurance plans or for uninsured patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Cremasco Medicina Diagnóstica provides integrated diagnostic medicine services through 12 physical units across Greater Vitória, Brazil. The company delivers five core service lines: Clinical Analysis (3,000+ lab test types with 24-hour digital results), Diagnostic Imaging (CT, MRI, ultrasound, digital radiology), Specialized Medical Consultations, Pathological Anatomy (digital microscopy and histopathology), and Molecular Biology (PCR, NGS, genetic panels, pharmacogenomics). Services are delivered in-center, via home collection, and through a digital patient portal, with billing handled primarily through 28+ health insurance provider networks.

Product overview

Cremasco Medicina Diagnóstica operates as a diagnostic medicine network offering five integrated core service lines: Clinical Analysis (laboratory testing with 3,000+ exam types), Diagnostic Imaging (CT, MRI, ultrasound, radiology), Specialized Consultations (multidisciplinary medical consultations with telemedicine), Pathological Anatomy (histopathology and cytology with digital microscopy), and Molecular Biology (PCR, genetic panels, NGS). All services are connected through a centralized patient results portal enabling longitudinal result tracking and physician sharing. The company operates 12 units across Greater Vitória in Espírito Santo, Brazil, with home collection services and accepts 28+ health insurance providers.

Differentiator

Problem solved

Functional benefit

Products and services

• Análises Clínicas (Clinical Analysis) Laboratory testing service offering over 3,000 types of examinations including hematology, biochemistry, hormones, immunology, and tumor markers, with dual validation, home collection options, and digital results delivered within 24 hours. Targeted at patients with health insurance coverage and referring physicians.
• Diagnóstico por Imagem (Diagnostic Imaging) Medical imaging service featuring multislice CT with low radiation dose and 3D reconstructions, 1.5T MRI with specialized protocols, color Doppler ultrasound, and digital radiology with dual specialist radiologist reading for accuracy. Targeted at patients requiring advanced imaging studies and referring physicians.
• Consultas Especializadas (Specialized Consultations) Multidisciplinary specialist consultation services including cardiology, endocrinology, gynecology, urology, and internal medicine, with integrated access to exams and images in real-time and telemedicine options for remote follow-up. Targeted at patients requiring specialist medical consultations.
• Anatomia Patológica (Pathological Anatomy) Histopathological and cytopathological analysis using digital microscopy with whole-slide imaging, including histological analysis of biopsies and surgical specimens, clinical cytology, immunohistochemistry, and permanent slide printing. Targeted at patients requiring biopsy analysis and referring physicians.
• Biologia Molecular (Molecular Biology) Molecular diagnostics service featuring high-sensitivity PCR for infectious disease diagnosis, genetic panels for cancer predisposition and hereditary diseases, pharmacogenomic tests for personalized medicine, and molecular research for oncological monitoring. Targeted at patients requiring precision medicine and specialist physicians.
• Portal de Resultados (Results Portal) Secure online platform for patients to access laboratory results, imaging reports, and pathology reports, compare longitudinal results over time, and share reports with their physicians, with 24/7 support. Targeted at all Cremasco patients.

Quantifiable outcome

• 50,000+ diagnostic tests processed per month
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• MDG Group (Grupo MDG)coreStrategic or Co-development PartnerParent organization and diagnostic network umbrella. Cremasco operates as part of the MDG Group alongside Unirad, Climp, Imagem Diagnóstico, Deomar, DES, CMC, and MedConsulta brands, providing integrated diagnostic services across Greater Vitória.
• UniradcoreStrategic or Co-development PartnerMDG Group subsidiary brand specializing in diagnostic imaging services, part of the integrated network operating alongside Cremasco units.
• ClimpminorStrategic or Co-development PartnerMDG Group subsidiary brand for diagnostic services, integrated into the group network.
• Imagem DiagnósticominorStrategic or Co-development PartnerMDG Group subsidiary brand for diagnostic imaging, integrated into the group network.
• DeomarminorStrategic or Co-development PartnerMDG Group subsidiary brand for diagnostic services in the Greater Vitória region.
• DES (Diagnóstico e Saúde)minorStrategic or Co-development PartnerMDG Group subsidiary brand for diagnostic and health services.
• CMCminorStrategic or Co-development PartnerMDG Group subsidiary brand for diagnostic services.
• MedConsultaminorStrategic or Co-development PartnerMDG Group subsidiary for medical consultations, providing telemedicine and specialist referrals within the integrated network.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Hermes Pardini: Brazilian reference laboratory with strong specialty and molecular testing franchise, plus outpatient units. Comparable to Cremasco on advanced diagnostics (NGS, pharmacogenomics) and clinical analysis breadth.
• Alliar Medicina Diagnóstica: Brazilian diagnostic chain operating imaging and clinical analysis centers with national footprint. Comparable integrated imaging + lab service model to Cremasco.
• Dasa: Brazil's largest diagnostic medicine network with hundreds of units, integrated lab and imaging, and growing molecular/precision medicine capabilities. Closest national-scale analog to Cremasco's integrated model.
• Grupo Fleury: One of Brazil's largest diagnostic medicine chains operating labs, imaging, and specialized consultations across multiple states. Direct overlap with Cremasco's full-service clinical analysis + imaging + molecular offering, but at national scale.
• Grupo Sabin: Major Brazilian diagnostic chain offering clinical analysis, imaging, and specialty consultations with strong presence across multiple states and active in health insurance partnerships. Comparable business model to Cremasco's integrated services.
• Laboratório Oswaldo Cruz: Long-established Brazilian diagnostic brand with clinical analysis, imaging, and pathology services across multiple regions. Comparable to Cremasco on brand longevity, insurance network acceptance, and integrated service offering.

Regional players

• DB Diagnósticos: Brazilian diagnostic chain with imaging and lab operations in selected states. Comparable regional-scale model with imaging + clinical analysis service mix similar to Cremasco's units.
• Grupo Exame: Diagnostic network active in northern Brazilian states with clinical analysis and imaging services. Comparable regional chain structure with similar service breadth to Cremasco.

Emerging players

• Hilab: Brazilian digital diagnostics startup offering remote/point-of-care lab testing and home collection. Competes with Cremasco's home collection and digital results portal offering, though without full imaging.

Direct peers

• Diagnósticos do Brasil (DASA regional brands): Regional diagnostic brands consolidated under Dasa and other national groups operating in Espírito Santo and adjacent states. Direct overlap with Cremasco's patient base in the same metro catchment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/cremascomedicina

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cremasco Medicina Diagnóstica